Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
Vishnu Priya Pulipati, Founder and Host of LipidCurious Podcast, Member of Institutional Review Ethics Board at Saint Francis Health System, shared on LinkedIn:
”Let’s talk about statins. I know… boring, right?
Most of us already know a lot about them.
But thinking of statins only as cholesterol drugs misses the bigger picture.
In many ways, statins are best understood as Anti-atherosclerotic therapies that modify plaque biology, vascular inflammation, and cardiovascular risk far beyond simple LDL reduction.
In this episode, we cover:
- Pleiotropic effects of statins beyond LDL-C lowering
- Choosing the right statin in special populations
- Why statins remain foundational therapy even in the era of newer lipid-lowering drugs
Bonus: Visual guide to help you navigate the episode.
Free CME/CE available for listening.
Listen at www.lipidcurious.com, Apple Podcasts, Spotify, or YouTube Podcasts.
Want a companion resource? Download the free LipidCurious Starter Kit.
Questions or feedback? [email protected]
Disclaimer: Educational content only. Not medical advice.
Clinicians should use independent clinical judgment and applicable guidelines.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025